Expert Review of Clinical Immunology
Expert Review of Clinical Immunology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 78. It has a price of 4000 €. It has an SJR impact factor of 1,125 and it has a best quartile of Q2. It has an SJR impact factor of 1,125.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,125
H-index
78
Docs (year)
129
Docs 3y
365
Total refs
11754
Cites 3y
1369
Citable 3y
323
Cites/Doc 2y
3.63
Ref/Doc
91.12
Immediate OA
4000 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Canakinumab for the treatment of systemic juvenile idiopathic arthritis
View moreUnderstanding the link between the IL-6 cytokine family and pregnancy: implications for future therapeutics
View moreCT-P13 in the treatment of rheumatoid arthritis
View moreCross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy
View moreCorrelation of serum protein biomarkers with disease activity in psoriatic arthritis
View moreComparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13)
View moreCommensal microbiota as a potential trigger of autoimmune uveitis
View moreClinical and biological markers of asthma control
View moreCinryze‚Ñ¢ (C1-inhibitor) for the treatment of hereditary angioedema
View moreChronic rejection of human kidney allografts
View moreCertolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis
View moreCD4+CD25+regulatory T-cell therapy
View moreCancer stem cells and tumor immunoediting: putting two and two together
View moreA focus on the use of subcutaneous C1-inhibitor for treatment of hereditary angioedema
View moreCanakinumab for the treatment of adult-onset Still's disease
View moreBiologics in pediatric Crohn's disease: is it time to move to an earlier therapeutic approach?
View moreAvoiding infections in transplant recipients: does the gut microbiota have a key role?
View moreAutoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum
View moreAnakinra in the treatment of rheumatic disease
View moreAlternate roles for immune regulators: establishing endometrial receptivity for implantation
View moreAllergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
View moreAllergen microbead arrays: the future of allergy diagnostics?
View moreAirway smooth muscle modulation and airway hyper-responsiveness in asthma: new cellular and molecular paradigms
View moreAdvances in proteomic techniques for biomarker discovery in COPD
View more